← Back to catalogue

Teco Diagnostics HDL Cholesterol Reagent Set

FDA UDI

Class I (US FDA UDI)

by Teco Diagnostics

Identity

Trade Name
Teco Diagnostics HDL Cholesterol Reagent Set FDA UDI
Generic Name
High density lipoprotein (HDL) cholesterol IVD, reagent FDA UDI
Device Name
Teco Diagnostics HDL Cholesterol Reagent Set is used for the quantitative determination of high density lipoprotein (HDL) in human serum. FDA UDI
Model / Reference
H511-30 FDA UDI
Description
Teco Diagnostics HDL Cholesterol Reagent Set is used for the quantitative determination of high density lipoprotein (HDL) in human serum. FDA UDI

Identifiers

Catalog Number
H511-30 FDA UDI
Primary DI / UDI-DI
10673486001938 FDA UDI
510(k) Number
K880176 FDA UDI
FDA Product Code
LBR FDA UDI
GMDN Term
High density lipoprotein (HDL) cholesterol IVD, reagent FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1475 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: High density lipoprotein (HDL) cholesterol IVD, reagent

Teco Diagnostics HDL Cholesterol Reagent Set by Teco Diagnostics — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as High density lipoprotein (HDL) cholesterol IVD, reagent.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Teco Diagnostics

Sources (1)

  • FDA UDI 56033f9a-8b99-4c24-b19c-6d2f555c9d5e 37 fields · synced Jun 8, 2026